Q4 for RVX and Zenith
|
5
|
Zenith Epigenetics
|
Oct 25, 2016 12:54PM
|
Actual chronology of posts by Fuzzy and Kelsee
|
1
|
Resverlogix Corp.
|
Oct 25, 2016 04:13PM
|
Re: OFF-TOPIC discussion set-up and in progress....
|
3
|
Resverlogix Corp.
|
Oct 25, 2016 05:02PM
|
biOasis Provides Further Details Regarding its Agreement with Rising Tide Equity
|
2
|
BIOASIS TECHNOLOGIES INC
|
Oct 25, 2016 10:29PM
|
Re: OFF-TOPIC discussion set-up and in progress....
|
5
|
Resverlogix Corp.
|
Oct 26, 2016 10:02AM
|
Re: News from a Chinese/Japenese Article about Zenith
|
2
|
Zenith Epigenetics
|
Oct 26, 2016 12:01PM
|
10/28/16 Financial Statement and MD&A on SEDAR
|
2
|
BIOASIS TECHNOLOGIES INC
|
Oct 29, 2016 11:04PM
|
Re: trial no 2
|
3
|
Zenith Epigenetics
|
Oct 30, 2016 04:32PM
|
Re: RVX-208 side effects
|
3
|
Resverlogix Corp.
|
Oct 30, 2016 10:56PM
|
Re: Crispr-cas9 Patent Dispute -- Off-topic? Or do we have a similar situation?
|
1
|
Resverlogix Corp.
|
Oct 31, 2016 11:32AM
|
Re: Crispr-cas9 Patent Dispute -- Off-topic? Or do we have a similar situation?
|
1
|
Resverlogix Corp.
|
Oct 31, 2016 11:47AM
|
Re: Happy Halloween all....
|
|
Resverlogix Corp.
|
Oct 31, 2016 12:07PM
|
Re: Happy Halloween all....
|
1
|
Resverlogix Corp.
|
Oct 31, 2016 12:31PM
|
Re: Reconciliation of comments made
|
5
|
Resverlogix Corp.
|
Oct 31, 2016 05:09PM
|
Re: Crispr-cas9 Patent Dispute -- Off-topic? Or do we have a similar situation?
|
4
|
Resverlogix Corp.
|
Oct 31, 2016 10:46PM
|
Re: New Article posted in the Journal of the American College of Cardiology
|
6
|
Resverlogix Corp.
|
Nov 01, 2016 01:42PM
|
Re: Pfizer's PCSK9 Inhibitor bococizumab - further development being scrapped
|
4
|
Resverlogix Corp.
|
Nov 01, 2016 02:03PM
|
Re: Japanese publication response from IR
|
6
|
Zenith Epigenetics
|
Nov 01, 2016 02:09PM
|
Re: Crispr-cas9 Patent Dispute -- Off-topic? Or do we have a similar situation?
|
3
|
Resverlogix Corp.
|
Nov 01, 2016 04:07PM
|
Re: Japanese publication response from IR
|
2
|
Zenith Epigenetics
|
Nov 01, 2016 04:09PM
|